Suppr超能文献

促肾上腺皮质激素释放因子样肽可增加人表皮样A-431细胞中的胞质[Ca2+]。

Corticotropin-releasing factor-like peptides increase cytosolic [Ca2+] in human epidermoid A-431 cells.

作者信息

Kiang J G

机构信息

Department of Clinical Physiology, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA.

出版信息

Eur J Pharmacol. 1997 Jun 25;329(2-3):237-44. doi: 10.1016/s0014-2999(97)00165-9.

Abstract

This study investigated whether sauvagine and urotensin I change [Ca2+]i in human epidermoid A-431 cells and whether these changes are correlated with their anti-edema properties in vivo. A-431 cells were used because they possess the corticotropin-releasing factor (CRF) receptor 2. Treatment with either sauvagine or urotensin I led to an immediate increase in [Ca2+]i, the magnitude of which depended on the concentration of the drug. Sauvagine was more effective than urotensin I, with a median effective concentration (EC50) of 1.4 +/- 0.2 fM, compared to an EC50 of 66 +/- 7 fM for urotensin I. Both were more effective at stimulating increases in [Ca2+]i than CRF (EC50 of 6.8 +/- 0.1 pM). There was a correlation between the EC50 for increasing [Ca2+]i and the median effective dose (ED50) for inhibiting edema induced by heating rat paw (r = 0.99). Removal of extracellular Ca2+ or incubation with La3+ eliminated the increase in [Ca2+]i stimulated by either peptide. Pretreatment with a CRF receptor antagonist reduced the increase in [Ca2+]i by these peptides. This occurred in an antagonist concentration-dependent manner, with median inhibitory concentrations (IC50) of 1.99 +/- 0.04 nM and 0.85 +/- 0.04 nM, respectively. Both pertussis toxin (an inhibitor of G proteins) and U-73122 (an inhibitor for inositol trisphosphate (InsP3) production) partially inhibited the increases. InsP3 was measured to determine whether these peptides mobilized Ca2+ from an InsP3-sensitive store. Both sauvagine and urotensin I increased InsP3. The InsP3 increases were inhibited by U-73 122 and CRF antagonist, but not by removal of external Ca2+. Both peptides elevated protein tyrosine phosphorylation. In summary, these peptides increase [Ca2+]i as a result of Ca2+ influx via CRF receptor-operated Ca2+ channels coupled to pertussis toxin-sensitive G proteins and a Ca2+ mobilization from InsP3-sensitive Ca2+ pools. Their in vivo effectiveness at inhibiting edema is related to their respective capacities to stimulate elevations of [Ca2+]i, supporting a role for intracellular Ca2+ in this process.

摘要

本研究调查了蛙皮素和尾加压素I是否会改变人表皮样A - 431细胞中的[Ca2+]i,以及这些变化是否与其体内抗水肿特性相关。使用A - 431细胞是因为它们具有促肾上腺皮质激素释放因子(CRF)受体2。用蛙皮素或尾加压素I处理均导致[Ca2+]i立即增加,其增加幅度取决于药物浓度。蛙皮素比尾加压素I更有效,其半数有效浓度(EC50)为1.4±0.2 fM,而尾加压素I的EC50为66±7 fM。两者在刺激[Ca2+]i增加方面均比CRF更有效(CRF的EC50为6.8±0.1 pM)。增加[Ca2+]i的EC50与抑制大鼠爪加热诱导的水肿的半数有效剂量(ED50)之间存在相关性(r = 0.99)。去除细胞外Ca2+或与La3+孵育可消除两种肽刺激引起的[Ca2+]i增加。用CRF受体拮抗剂预处理可减少这些肽引起的[Ca2+]i增加。这以拮抗剂浓度依赖性方式发生,半数抑制浓度(IC50)分别为1.99±0.04 nM和0.85±0.04 nM。百日咳毒素(一种G蛋白抑制剂)和U - 73122(一种肌醇三磷酸(InsP3)生成抑制剂)均部分抑制了[Ca2+]i的增加。检测InsP3以确定这些肽是否从InsP3敏感储存库中动员Ca2+。蛙皮素和尾加压素I均增加了InsP3。InsP3的增加被U - 73122和CRF拮抗剂抑制,但未被去除细胞外Ca2+抑制。两种肽均提高了蛋白质酪氨酸磷酸化水平。总之,这些肽通过与百日咳毒素敏感的G蛋白偶联的CRF受体操纵的Ca2+通道引起Ca2+内流以及从InsP3敏感的Ca2+池动员Ca2+,从而增加[Ca2+]i。它们在体内抑制水肿的有效性与其各自刺激[Ca2+]i升高的能力相关,支持细胞内Ca2+在此过程中发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验